MSN Laboratories Private Limited Carfilzomib Export Data — India (DGFT 2022–2026)

Name: MSN Laboratories Private Limited Carfilzomib Export Records India — #1 Exporter, 19 Shipments, $90.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Carfilzomib

India Pharmaceutical Trade Intelligence

$1.2M65 Suppliers47 CountriesHS 30049049

ExportsIndia → RUSSIA60.7%India → CHILE7.4%

ImportsIRELAND → India$9.4M CANADA → India$518.8K

#1 Supplier: MSN LABORATORIES

MSN Laboratories Private Limited — Carfilzomib Exporter #1 | $90.9K Trade Value | TransData Nexus | TransData Nexus

MSN Laboratories Private Limited — Carfilzomib Exporter Profile

Indian Pharmaceutical Exporter · #1 for Carfilzomib · $90.9K export value · DGFT Verified

MSN Laboratories Private Limited is the #1 Indian exporter of Carfilzomib with $90.9K in export value and 19 verified shipments. MSN Laboratories Private Limited holds a 7.5% market share in Carfilzomib exports across 4 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.

MSN Laboratories Private Limited — Carfilzomib Export Profile: Buyers & Destinations

MSN Laboratories Private Limited Carfilzomib export treemap — buyers and destination countries | TransData Nexus

Where Does MSN Laboratories Private Limited Export Carfilzomib?

Country	Value	Shipments	Share
CHILE	$50.0K	1	97.7%
BRAZIL	$1.2K	13	2.3%
UNITED STATES	$0	3	0.0%
CHINA	$0	2	0.0%

MSN Laboratories Private Limited exports Carfilzomib to 4 countries. The largest destination is accounting for 97.7% of MSN Laboratories Private Limited's Carfilzomib shipments. These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Carfilzomib from MSN Laboratories Private Limited?

Buyer	Country	Value	Orders
MSN LABS CHILE SPARUT	CHILE	$50.0K	1
MSN LABS BRASIL LTDA	BRAZIL	$484	3
SAFE LAB LOGISTICS SAFELAB TRANSPORTES LIMITED A RUA	BRAZIL	$253	4
SANDOZ DO BRASIL INDUSTRIA FARMACEUTICA AS T DEPARTMENT RUA	BRAZIL	$240	1
SANDOZ DO BRASIL INDUSTRIA	BRAZIL	$158	2
SANDOZ DO BRASIL INDUSTRIA FARMACE	BRAZIL	$47	2
NANOTECH PHARMA	UNITED STATES	$0	3
MR. CAIHAIHAI,	CHINA	$0	2
MSN LABS BRASIL LIMITEDA	BRAZIL	$0	1

MSN Laboratories Private Limited supplies Carfilzomib to 9 buyers globally. The largest buyer is MSN LABS CHILE SPARUT (CHILE), followed by MSN LABS BRASIL LTDA (BRAZIL) and SAFE LAB LOGISTICS SAFELAB TRANSPORTES LIMITED A RUA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Carfilzomib Formulations Does MSN Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
MSN FORMULATIONS PRODUCT: XOMICIB 60MGCARFILZOMIB FOR INJECTION 60 MG/VIAL1X1'S PACK 40 NO'S OF FREE SAMPLES	$50.0K	1
MSN PHARMACEUTICAL PRODUCT NAME: PLACEBOFOR CARFILZOMIB	$240	1
MSN PHARMACEUTICAL PRODUCT NAME: CARFILZOMIB FOR INJECTION 60MG/ VIAL	$229	2
CARFILZOMIB FOR INJ 60MG/VIAL	$200	2
CARFILZOMIB FOR INJECTION 60MG/VIAL	$147	1
PLACEBO FOR CARFILZOMIB FOR INJECTION V	$137	1
PLACEBO FOR CARFILZOMIB FOR INJECTION(QTY:0.002 PAC)(SAMPLES FOR TESTING PURPOSEONLY)	$116	1
PLACEBO FOR CARFILZOMIB FOR INJECTION 60MG VIAL QTY 120 NOS TESTING PURPOSE ONLY	$47	2
CARFILZOMIB FOR INJECTION 60 MG/VIAL(QTY:250 PAC)(SAMPLES FOR TESTING PURPOSE ONLY)	$42	1
MSN PHARMACEUTICAL PRODUCT NAME: PLACEBOFOR CARFILZOMIB FOR INJECTION 60MG/VIAL	$24	2

MSN Laboratories Private Limited exports 15 distinct Carfilzomib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MSN FORMULATIONS PRODUCT: XOMICIB 60MGCARFILZOMIB FOR INJECT with 1 shipments worth $50.0K.

How Does MSN Laboratories Private Limited Compare to Nearest Carfilzomib Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MSN LABORATORIES PRIVATE LIMITED ★	$90.9K	19	4	$4.8K
2	SARTAJ PHARMA PRIVATE LIMITED	$32.9K	7	3	$4.7K
3	NATCO PHARMA LIMITED	$31.8K	7	2	$4.5K

MSN Laboratories Private Limited ranks #1 among 65 Indian Carfilzomib exporters. Average shipment value of $4.8K compared to the market average of $4.0K. The closest competitors by value are SARTAJ PHARMA PRIVATE LIMITED and NATCO PHARMA LIMITED.

Which Indian Ports Ship Carfilzomib Exports?

Port	Shipments	% Share
SAHAR AIR	38	18.7%
SAHAR AIR CARGO ACC (INBOM4)	32	15.8%
DELHI AIR	26	12.8%
HYDERABAD ACC (INHYD4)	19	9.4%
Bombay Air	19	9.4%
DELHI AIR CARGO ACC (INDEL4)	9	4.4%
HYDERABAD AIR	9	4.4%
Bombay Air Cargo	9	4.4%

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Carfilzomib Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.

MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Carfilzomib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 19 individual customs records matching MSN Laboratories Private Limited exporting Carfilzomib, covering 15 formulations to 4 countries via 9 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 47+ countries, 105+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Carfilzomib

Carfilzomib

MSN Laboratories Private Limited — Carfilzomib Exporter Profile

MSN Laboratories Private Limited — Carfilzomib Export Profile: Buyers & Destinations

Where Does MSN Laboratories Private Limited Export Carfilzomib?

Who Are the Top Buyers of Carfilzomib from MSN Laboratories Private Limited?

What Is India's Total Carfilzomib Export Value and How Much Does MSN Laboratories Private Limited Contribute?

What Is the Average Shipment Value for MSN Laboratories Private Limited's Carfilzomib Exports?

How Does MSN Laboratories Private Limited Compare to Other Indian Carfilzomib Exporters?

What Carfilzomib Formulations Does MSN Laboratories Private Limited Export?

Regulatory Requirements: Exporting Carfilzomib to Key Markets

Brazil — ANVISA

United States — FDA

How Does MSN Laboratories Private Limited Compare to Nearest Carfilzomib Exporters?

Which Indian Ports Ship Carfilzomib Exports?

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Carfilzomib Exports

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

About MSN Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Carfilzomib Export Data from MSN Laboratories Private Limited

Carfilzomib Stats

Company Overview

Top Products by MSN Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source